| scholarly article | Q13442814 |
| P50 | author | Pengyu Ren | Q45710729 |
| Jiney Jose | Q61822666 | ||
| P2093 | author name string | Chunli Yan | |
| Yue Shi | |||
| Qiantao Wang | |||
| Kevin N Dalby | |||
| Ashwini K Devkota | |||
| Tamer S Kaoud | |||
| Eun Jeong Cho | |||
| Ramakrishna Edupuganti | |||
| P2860 | cites work | Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase | Q24319188 |
| Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences | Q24336098 | ||
| PROCHECK: a program to check the stereochemical quality of protein structures | Q26778411 | ||
| Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity | Q27632346 | ||
| Crystal Structure of the -Kinase Domain of Dictyostelium Myosin Heavy Chain Kinase A | Q27660090 | ||
| Discovery of Potent and Selective Covalent Inhibitors of JNK | Q27676927 | ||
| Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles | Q27678280 | ||
| VMD: visual molecular dynamics | Q27860554 | ||
| Comparative protein modelling by satisfaction of spatial restraints | Q27860866 | ||
| The Jalview Java alignment editor | Q27861026 | ||
| Elongation factor-2 kinase and its newly discovered relatives | Q28208231 | ||
| Recognition of errors in three-dimensional structures of proteins | Q28249658 | ||
| Calcium/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence | Q28259597 | ||
| The Role of Eukaryotic Elongation Factor 2 Kinase in Rapid Antidepressant Action of Ketamine | Q28276943 | ||
| The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation | Q28291406 | ||
| Targeting cancer with small molecule kinase inhibitors | Q29547395 | ||
| Modeling of loops in protein structures | Q29615861 | ||
| NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses | Q30471587 | ||
| Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database | Q30494222 | ||
| Conformer generation with OMEGA: learning from the data set and the analysis of failures | Q30574063 | ||
| Targeting RSK: an overview of small molecule inhibitors | Q33376012 | ||
| Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition | Q33543073 | ||
| A structure-guided approach to creating covalent FGFR inhibitors | Q34061522 | ||
| Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer | Q34387697 | ||
| Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides. | Q34573054 | ||
| High-throughput screens for eEF-2 kinase | Q35002039 | ||
| Alpha-kinases: analysis of the family and comparison with conventional protein kinases | Q35721480 | ||
| Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli. | Q36075643 | ||
| Activated ERK2 Is a Monomer in Vitro with or without Divalent Cations and When Complexed to the Cytoplasmic Scaffold PEA-15 | Q36107198 | ||
| From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules | Q36243062 | ||
| Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer | Q36617301 | ||
| Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact | Q36903990 | ||
| Development of nitrile-based peptidic inhibitors of cysteine cathepsins | Q37694669 | ||
| Targeted covalent drugs of the kinase family | Q37770660 | ||
| Reversible covalent binding of peptide nitriles to papain | Q38534345 | ||
| 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor | Q39454084 | ||
| Irreversible Nek2 kinase inhibitors with cellular activity | Q39533198 | ||
| In vivo efficacy of natural product-inspired irreversible kinase inhibitors | Q39681513 | ||
| Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy | Q39879662 | ||
| Structural bioinformatics-based design of selective, irreversible kinase inhibitors | Q40307105 | ||
| Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines | Q40622035 | ||
| Transient inhibition of protein synthesis induces expression of proto-oncogenes and stimulates resting cells to enter the cell cycle | Q41263722 | ||
| Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors. | Q42750517 | ||
| Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase | Q42795858 | ||
| Empirical scoring functions for advanced protein-ligand docking with PLANTS. | Q51857293 | ||
| Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine | Q54216581 | ||
| Diverse, high-quality test set for the validation of protein-ligand docking performance. | Q55043208 | ||
| Comparison of Shape-Matching and Docking as Virtual Screening Tools | Q56853909 | ||
| Cysteine Proteases and Their Inhibitors | Q61066438 | ||
| Inhibition of papain by nitriles: mechanistic studies using NMR and kinetic measurements | Q69742729 | ||
| P433 | issue | 16 | |
| P304 | page(s) | 2435-2442 | |
| P577 | publication date | 2014-09-15 | |
| P1433 | published in | ChemBioChem | Q634395 |
| P1476 | title | Reversible covalent inhibition of eEF-2K by carbonitriles | |
| P478 | volume | 15 |
| Q54978227 | Structural Dynamics of the Activation of Elongation Factor 2 Kinase by Ca2+-Calmodulin. |
| Q27727833 | Structure of the C-Terminal Helical Repeat Domain of Eukaryotic Elongation Factor 2 Kinase |
| Q38931379 | Targeted Covalent Inhibitors for Drug Design. |
| Q40608421 | Using docking and alchemical free energy approach to determine the binding mechanism of eEF2K inhibitors and prioritizing the compound synthesis |
Search more.